• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

根治性膀胱切除术患者的健康相关生活质量:一项大型前瞻性队列研究的结果。

Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort.

机构信息

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

Eur Urol. 2022 Mar;81(3):294-304. doi: 10.1016/j.eururo.2021.09.018. Epub 2021 Oct 8.

DOI:10.1016/j.eururo.2021.09.018
PMID:34629182
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8891075/
Abstract

BACKGROUND

Radical cystectomy (RC) has the potential for profound changes to health-related quality of life (HRQOL).

OBJECTIVE

To evaluate a broad range of HRQOL outcomes in a large RC cohort.

DESIGN, SETTING, AND PARTICIPANTS: A single-center prospective study enrolled RC patients from 2008 to 2014. We collected 14 separate patient-reported outcome measures at the presurgical visit and at 3, 6, 12, 18, and 24 mo after RC.

OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS

To visualize the patterns of recovery over time across domains, we used generalized estimating equations (GEEs) with nonlinear terms. Given substantial differences in patient selection for the type of urinary diversion, we separately modeled longitudinal HRQOL within conduit and continent diversion groups. The mean pre-RC scores were compared to illustrate the baseline HRQOL differences between diversion groups.

RESULTS AND LIMITATIONS

The analyzed cohort included 411 patients (n = 205 ileal conduit, n = 206 continent diversion). At baseline, patients receiving continent diversion reported better mean physical (p < 0.001), urinary (p = 0.006), and sexual function (p < 0.001), but lower social function (p = 0.015). After RC, GEE modeling showed physical function scores decreasing 5/100 points by 6 mo, and subsequently stabilizing or returning to baseline. By 12 mo, social function improved by 10/100 points among continent diversions, while remaining stable among ileal conduits. Global quality of life exceeded baseline scores by 6 mo. Sexual function scores were low before RC, with limited recovery. Psychosocial domains were stable or improved, except for 10/100-point worsening of body image among ileal conduits.

CONCLUSIONS

RC patients reported favorable HRQOL recovery within 24 mo in most areas other than body image (ileal conduits) and sexual function (both). Importantly, large measurable decreases in scores were not reported by 3 mo after RC. These contemporary outcomes and the excellent locoregional control provided by RC further support it as the gold standard therapy for high-risk bladder cancer.

PATIENT SUMMARY

We review quality of life in the 24 mo following radical cystectomy. Large decreases in health-related quality of life were not reported, with most areas returning to, or exceeding, baseline, except for sexual function and body image.

摘要

背景

根治性膀胱切除术(RC)有可能对健康相关生活质量(HRQOL)产生深远影响。

目的

评估大型 RC 队列中广泛的 HRQOL 结果。

设计、地点和参与者:一项单中心前瞻性研究招募了 2008 年至 2014 年间的 RC 患者。我们在术前就诊时以及 RC 后 3、6、12、18 和 24 个月收集了 14 项单独的患者报告结局测量。

测量和统计分析

为了直观地观察各领域随时间恢复的模式,我们使用具有非线性项的广义估计方程(GEE)。鉴于尿路改道类型的患者选择存在显著差异,我们分别在导管和 continent 分流组内对纵向 HRQOL 进行建模。比较术前平均评分以说明分流组之间的基线 HRQOL 差异。

结果和局限性

分析队列包括 411 名患者(n=205 例回肠导管,n=206 例 continent 分流)。基线时,接受 continent 分流的患者报告了更好的平均身体(p<0.001)、尿(p=0.006)和性功能(p<0.001),但社会功能较低(p=0.015)。RC 后,GEE 建模显示身体功能评分在 6 个月时下降 5/100 分,随后稳定或恢复基线。到 12 个月时,continent 分流的社会功能改善了 10/100 分,而 ileal 导管保持稳定。全球生活质量在 6 个月时超过基线评分。RC 前性功能评分较低,恢复有限。心理社会领域稳定或改善,除了 ileal 导管中有 10/100 分的身体形象恶化。

结论

RC 患者在 24 个月内报告了大多数领域(除了 ileal 导管的身体形象和两者的性功能)以外的 HRQOL 恢复良好。重要的是,RC 后 3 个月内没有报告评分大幅下降。这些现代结果和 RC 提供的出色局部区域控制进一步支持它作为高危膀胱癌的金标准治疗。

患者总结

我们回顾了 RC 后 24 个月的生活质量。没有报告健康相关生活质量大幅下降,大多数领域恢复到或超过基线,除了性功能和身体形象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/8891075/e4498833e30c/nihms-1742931-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/8891075/56f086a07fd7/nihms-1742931-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/8891075/c6235663fc51/nihms-1742931-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/8891075/577b56d9cc55/nihms-1742931-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/8891075/e4498833e30c/nihms-1742931-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/8891075/56f086a07fd7/nihms-1742931-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/8891075/c6235663fc51/nihms-1742931-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/8891075/577b56d9cc55/nihms-1742931-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19bc/8891075/e4498833e30c/nihms-1742931-f0004.jpg

相似文献

1
Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort.根治性膀胱切除术患者的健康相关生活质量:一项大型前瞻性队列研究的结果。
Eur Urol. 2022 Mar;81(3):294-304. doi: 10.1016/j.eururo.2021.09.018. Epub 2021 Oct 8.
2
Midterm Health-related Quality of Life After Radical Cystectomy: A Propensity Score-matched Analysis.根治性膀胱切除术后的中期健康相关生活质量:一项倾向评分匹配分析。
Eur Urol Focus. 2020 Jul 15;6(4):704-710. doi: 10.1016/j.euf.2019.02.017. Epub 2019 Mar 7.
3
Retrosigmoid Versus Traditional Ileal Conduit for Urinary Diversion After Radical Cystectomy.根治性膀胱切除术后的回肠后位与传统回肠膀胱术式用于尿流改道的比较。
Eur Urol. 2019 Feb;75(2):294-299. doi: 10.1016/j.eururo.2018.06.023. Epub 2018 Jul 4.
4
Recovery of health-related quality of life in patients undergoing robot-assisted radical cystectomy with intracorporeal diversion.机器人辅助根治性膀胱切除术伴体腔内转流术患者健康相关生活质量的恢复。
BJU Int. 2022 Jan;129(1):72-79. doi: 10.1111/bju.15505. Epub 2021 Jul 5.
5
Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes.膀胱癌根治性膀胱切除术后的尿流改道:选择、患者选择和结果。
BJU Int. 2014 Jan;113(1):11-23. doi: 10.1111/bju.12121.
6
Prospective health-related quality of life analysis for patients undergoing radical cystectomy and urinary diversion.接受根治性膀胱切除术和尿流改道患者的前瞻性健康相关生活质量分析。
Urology. 2014 Oct;84(4):808-13. doi: 10.1016/j.urology.2014.05.046. Epub 2014 Aug 8.
7
Health-related Quality of Life After Radical Cystectomy: A Cross-sectional Study With Matched-pair Analysis on Ileal Conduit vs Ileal Orthotopic Neobladder Diversion.根治性膀胱切除术后的健康相关生活质量:一项关于回肠导管与回肠原位新膀胱改道的配对分析横断面研究。
Urology. 2017 Oct;108:82-89. doi: 10.1016/j.urology.2017.06.022. Epub 2017 Jun 23.
8
Longitudinal Health Related Quality of Life After Open Radical Cystectomy: Comparison of Ileal Conduit, Indiana Pouch, and Orthotopic Neobladder.开放式根治性膀胱切除术后排尿功能相关生活质量的纵向研究:回肠导管、印第安纳袋和原位新膀胱的比较。
Urology. 2021 Jun;152:184-189. doi: 10.1016/j.urology.2020.12.036. Epub 2021 Jan 19.
9
Ileal conduit: standard urinary diversion for elderly patients undergoing radical cystectomy.回肠膀胱术:老年患者根治性膀胱切除术后的标准尿流改道术。
World J Urol. 2016 Jan;34(1):19-24. doi: 10.1007/s00345-015-1706-1. Epub 2015 Oct 16.
10
Comparison of Patient-reported Health-related Quality of Life Between Open Radical Cystectomy and Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion: Interim Analysis of a Randomised Controlled Trial.开放式根治性膀胱切除术与机器人辅助根治性膀胱切除术联合体腔内尿流改道术治疗患者报告的健康相关生活质量比较:一项随机对照试验的中期分析。
Eur Urol Focus. 2022 Mar;8(2):465-471. doi: 10.1016/j.euf.2021.03.002. Epub 2021 Mar 10.

引用本文的文献

1
Re-appraisal of Standard of Care Imaging to Identify Predictors of Treatment Outcomes among Patients with Bladder and Upper Tract Urothelial Cancers.重新评估护理标准影像检查以确定膀胱和上尿路尿路上皮癌患者的治疗结果预测因素
Curr Urol Rep. 2025 Jun 21;26(1):51. doi: 10.1007/s11934-025-01278-0.
2
Current State of Bladder Preservation in High Grade Non-Muscle Invasive Bladder Cancer and Localized Muscle Invasive Bladder Cancer.高级别非肌层浸润性膀胱癌和局限性肌层浸润性膀胱癌的膀胱保留现状
Curr Oncol Rep. 2025 Apr 30. doi: 10.1007/s11912-025-01657-3.
3
Multiscale screening and identifying specific targets for artesunate in suppressing bladder cancer.

本文引用的文献

1
Quality of Life After Bladder Cancer: A Cross-sectional Survey of Patient-reported Outcomes.膀胱癌患者的生活质量:一项基于患者报告结局的横断面调查。
Eur Urol. 2021 May;79(5):621-632. doi: 10.1016/j.eururo.2021.01.032. Epub 2021 Feb 10.
2
Setting the stage for bladder preservation.为膀胱保留奠定基础。
Urol Oncol. 2021 Apr;39(4):209-212. doi: 10.1016/j.urolonc.2020.09.001. Epub 2020 Sep 30.
3
Ileal conduit or orthotopic neobladder: selection and contemporary patterns of use.回肠膀胱造口术或原位新膀胱术:选择和当代应用模式。
多尺度筛选和鉴定青蒿琥酯抑制膀胱癌的特定靶点。
Front Pharmacol. 2025 Apr 15;16:1584502. doi: 10.3389/fphar.2025.1584502. eCollection 2025.
4
Management of Patients with Muscle-Invasive Bladder Cancer Achieving A Clinical Complete Response after Neoadjuvant Therapy: Evidence and Consideration for Active Surveillance.新辅助治疗后达到临床完全缓解的肌层浸润性膀胱癌患者的管理:主动监测的证据与考量
Curr Urol Rep. 2025 Apr 10;26(1):36. doi: 10.1007/s11934-025-01264-6.
5
Advocating female genital-sparing cystectomy as the standard of care for women with bladder cancer Re: "2025 Canadian Urological Association Guideline: Muscle-invasive bladder cancer" (Can Urol Assoc J 2025;19:E1-16).倡导保留女性生殖器的膀胱切除术作为膀胱癌女性患者的护理标准 回复:《2025年加拿大泌尿外科协会指南:肌层浸润性膀胱癌》(《加拿大泌尿外科协会杂志》2025年;19:E1 - 16)
Can Urol Assoc J. 2025 Apr;19(4):E138-E139. doi: 10.5489/cuaj.9142.
6
Prospective comparative study of quality of life in patients with bladder cancer undergoing cystectomy with ileal conduit or bladder preservation.接受回肠代膀胱术或膀胱保留术的膀胱癌患者生活质量的前瞻性比较研究。
BMJ Oncol. 2024 Aug 13;3(1):e000435. doi: 10.1136/bmjonc-2024-000435. eCollection 2024.
7
The Global RAdical Cystectomy Evaluation and Management (GRACEM) pathway: single-centre prospective observational cohort study protocol.全球根治性膀胱切除术评估与管理(GRACEM)路径:单中心前瞻性观察性队列研究方案
BJUI Compass. 2025 Jan 7;6(1):e376. doi: 10.1002/bco2.376. eCollection 2025 Jan.
8
A multicenter study of perioperative and functional outcomes of open vs. robot assisted uretero-enteric reimplantation after radical cystectomy.一项关于根治性膀胱切除术后开放与机器人辅助输尿管肠再植术围手术期及功能结局的多中心研究。
World J Urol. 2025 Jan 16;43(1):74. doi: 10.1007/s00345-024-05435-x.
9
Impact of late effects after treatment for bladder cancer with radical cystectomy on Quality of life: a case-control study.根治性膀胱切除术后膀胱癌治疗晚期效应对生活质量的影响:一项病例对照研究。
Acta Oncol. 2025 Jan 8;64:27-33. doi: 10.2340/1651-226X.2025.41040.
10
PD-L1 expression in high-risk non-muscle invasive bladder cancer is not a biomarker of response to BCG.高危非肌层浸润性膀胱癌中程序性死亡受体配体1(PD-L1)的表达并非卡介苗(BCG)治疗反应的生物标志物。
World J Urol. 2025 Jan 3;43(1):57. doi: 10.1007/s00345-024-05392-5.
Curr Opin Urol. 2020 May;30(3):415-420. doi: 10.1097/MOU.0000000000000738.
4
Chemoradiation Vs Radical Cystectomy for Muscle-invasive Bladder Cancer: A Propensity Score-weighted Comparative Analysis Using the National Cancer Database.放化疗与根治性膀胱切除术治疗肌层浸润性膀胱癌:基于国家癌症数据库的倾向评分加权比较分析。
Urology. 2019 Nov;133:164-174. doi: 10.1016/j.urology.2019.05.062. Epub 2019 Aug 8.
5
Midterm Health-related Quality of Life After Radical Cystectomy: A Propensity Score-matched Analysis.根治性膀胱切除术后的中期健康相关生活质量:一项倾向评分匹配分析。
Eur Urol Focus. 2020 Jul 15;6(4):704-710. doi: 10.1016/j.euf.2019.02.017. Epub 2019 Mar 7.
6
Leveraging Latent Dirichlet Allocation in processing free-text personal goals among patients undergoing bladder cancer surgery.利用潜在狄利克雷分配在处理膀胱癌手术患者的自由文本个人目标。
Qual Life Res. 2019 Jun;28(6):1441-1455. doi: 10.1007/s11136-019-02132-w. Epub 2019 Feb 23.
7
Perceptions of Response Burden Associated with Completion of Patient-Reported Outcome Assessments in Oncology.患者报告结局评估完成负担的认知:肿瘤学视角。
Value Health. 2019 Feb;22(2):225-230. doi: 10.1016/j.jval.2018.07.875. Epub 2018 Aug 31.
8
Quality of Life After Radical Cystectomy.根治性膀胱切除术后的生活质量
Urol Clin North Am. 2018 May;45(2):249-256. doi: 10.1016/j.ucl.2017.12.008. Epub 2018 Feb 21.
9
Is Health-Related Quality of Life after Radical Cystectomy Using Validated Questionnaires Really Better in Patients with Ileal Orthotopic Neobladder Compared to Ileal Conduit: A Meta-Analysis of Retrospective Comparative Studies.与回肠导管术相比,使用经过验证的问卷评估,行根治性膀胱切除术后接受回肠原位新膀胱术的患者的健康相关生活质量真的更好吗:一项回顾性比较研究的荟萃分析
Curr Urol. 2017 Jul;10(2):57-68. doi: 10.1159/000447153. Epub 2017 May 30.
10
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline.非转移性肌肉浸润性膀胱癌治疗:AUA/ASCO/ASTRO/SUO 指南。
J Urol. 2017 Sep;198(3):552-559. doi: 10.1016/j.juro.2017.04.086. Epub 2017 Apr 26.